Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
drug prices
6
×
life sciences
national
national blog main
national top stories
new york top stories
novartis
6
×
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
pfizer
abbvie
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
deals
eli lilly
gene therapy
gilead sciences
What
drug
bio
price
roundup
companies
home
new
patients
pharmaceutical
prices
today
acquisitions
airport
albert
alzheimer’s
annual
apocalypse
approval
approved
atrophy
away
beds
biggest
biogen’s
biopharmaceutical
bourla
bringing
celgene
ceo
ceos
company
convo
crispr
daily
days
dc
different
earlier
evrysdi
executives
Language
unknown
unset
Current search:
novartis
×
" drug prices "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More